For the quarter ending 2025-09-30, BIOF had $87,168 increase in cash & cash equivalents over the period. -$86,717 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Accounts payable and accrued liabilities | - | 31,495 |
| Net income (loss) | -422,547 | -1,164,585 |
| Depreciation and amortization | 31,417 | 96,023 |
| Stock based compensation for services | 288,699 | 465,557 |
| Issuance of warrants for interest | 6,328 | 18,149 |
| Prepaid expenses | 0 | 300 |
| Accounts payable | -49,371 | - |
| Deferred wages and directors fees related party | 30,529 | 251,561 |
| Interest payable - related party | -9,219 | 0 |
| Right of use lease | -1,690 | -3,377 |
| Net cash used in operating activities | -153,969 | -298,723 |
| Net purchase of property and equipment | -67,252 | 136,151 |
| Deposit on land | 0 | 50,000 |
| Patent and trademark costs | 1,115 | 7,147 |
| Net cash used in investing activities | 66,137 | -193,298 |
| Proceeds from exercise of warrants | 0 | 6,250 |
| Proceeds from the issuance of notes payable - rp | 0 | 185,000 |
| Proceeds from issuance of common stock and warrants | 175,000 | 260,000 |
| Proceeds from the issuance of convertible notes - other | - | 0 |
| Net cash provided by financing activities | 175,000 | 451,250 |
| Net increase (decrease) in cash and cash equivalents | 87,168 | -40,771 |
| Cash and cash equivalents at beginning of period | 48,797 | - |
| Cash and cash equivalents at end of period | 95,194 | - |
BLUE BIOFUELS, INC. (BIOF)
BLUE BIOFUELS, INC. (BIOF)